Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4303-4314

  Gaikwad, Swapnil ^a   Ingle, Avinash ^a   Gade, Aniket ^a   Rai, Mahendra ^a   Falanga, Annarita ^b   Incoronato, Novella ^b   Russo, Luigi ^b   Galdiero, Stefania ^b   Galdiero, Massimilano ^b  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antiviral; Herpes simplex virus; Parainfluenza virus; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE;

ANTIVIRAL ACTIVITY; ARTICLE; BANANA; CATHARANTHUS ROSEUS; DRYOPTERIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; NONHUMAN; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELAGINELLA; SYZYGIUM CUMINI; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; VIRUS INFECTIVITY; VIRUS REPLICATION; ZETA POTENTIAL;

ANTIVIRAL; HERPES SIMPLEX VIRUS; PARAINFLUENZA VIRUS; SILVER NANOPARTICLES;

ANIMALS; ANTIVIRAL AGENTS; FUNGI; METAL NANOPARTICLES; PARAINFLUENZA VIRUS 3, HUMAN; PLANTS; SILVER; SIMPLEXVIRUS; VERO CELLS;

EID: 84887334090     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S50070     Document Type: Article

References (47)

1. Tauxe RV. Emerging foodborne pathogens. Int J Food Microbiol. 2002;78:31-41.
2. Domingo E. Mechanisms of viral emergence. Vet Res. 2010;41:38.
3. Field AK, Biron KK. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev. 1994;7:1-13.
4. Mancini DAP, Torres RP, Pinto JR, Mancini-Filho J. Inhibition of DNA virus: Herpes-1 (HSV-1) in cellular culture replication, through an antioxidant treatment extracted from rosemary spice. Braz J Pharm Sci. 2009;45:127.
5. Hashem AM, Flaman AS, Farnsworth A, et al. Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases. PLoS One. 2009;4:e8350.
6. Singh R, Nalwa HS. Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J Biomed Nanotechnol. 2011;7:489-503.
7. Nair B, Pradeep T. Coalescence of nanoclusters and formation of submicron crystallites assisted by lactobacillus strains. Cryst Growth Des. 2002;2:293-298.
8. Ahmad A, Senapati S, Khan MI, et al. Intracellular synthesis of gold nanoparticles by a novel alkalotolerant actinomycete, Rhodococcus species. Nanotechnology. 2003;14:824-828.
9. Robinson MG, Brown LN, Hall BD. Effect of gold (III) on the fouling diatom Amphora coffeaeformis: uptake, toxicity and interactions with copper. Biofouling. 1997;11:59-79.
10. Gardea-Torresdey JL, Gomez E, Peralta-Videa JR, Parsons JG, Troiani H, Jose-Yacaman M. Alfalfa sprouts: a natural source for the synthesis of silver nanoparticles. Langmuir. 2003;19:1357-1361.
11. Kesharwani JG, Rai MK, Hwang J, Yoon KI. Phytofabrication of silver nanoparticles by leaf extract of Daturametel: hypothetical mechanism involved in synthesis. Journal of Bionanoscience. 2009;3:39-44.
12. Bonde SR, Rathod DP, Ingle AP, Ade RB, Gade AK, Rai MK. First report of Murraya koenigii mediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria. Nanoscience Methods. 2012;1:25-36.
13. Gade AK, Bonde PP, Ingle AP, Marcato PD, Duran N, Rai MK. Exploitation of Aspergillus niger for fabrication of silver nanoparticles. J Biobased Mater Bio. 2008;2:243-247.
14. Birla SS, Tiwari VV, Gade AK, Ingle AP, Yadav AP, Rai MK. Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol. 2009;48:173-179.
15. Gajbhiye M, Kesharwani J, Ingle A, Gade A, Rai M. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine. 2009;5: 382-386.
16. Ingle A, Gade A, Pierrat S, Sonnichsen C, Rai M. Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci. 2008;4: 141-144.
17. Ingle A, Rai M, Gade A, Bawaskar M. Fusarium solani: a novel biological agent for the extracellular synthesis of silver nanoparticles. J Nanopart Res. 2009;11:2079-2085.
18. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine. 2010;6:103-109.
19. Raheman F, Deshmukh S, Ingle A, Gade A, Rai M. Silver nanoparticles: novel antimicrobial agent synthesized from an endophytic fungus pestalotia sp. isolated from leaves of Syzygium cumini (L). Nano Biomed Eng. 2011;3:174-178.
20. Li G, He D, Qian Y, et al. Fungus-mediated green synthesis of silver nanoparticles using Aspergillus terreus. Int J Mol Sci. 2012;13: 466-476.
21. Moazeni M, Rashidi N, Shahverdi AR, Noorbakhsh F, Rezaie S. Extracellular production of silver nanoparticles by using three common species of dermatophytes: Trichophyton rubrum, Trichophyton mentagrophytes and Microsporum canis. Iran Biomed J. 2012;16: 52-58.
22. Jogee PS, Ingle AB, Gupta IR, Bonde SR, Rai MK. Detection and management of mycotoxigenic fungi in nuts and dry fruits. Acta Hortic. 2012;963:69.
23. Cao XL, Cheng C, Ma YL, Zhao CS. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J Mater Sci Mater Med. 2010;21:2861-2868.
24. Devi LS, Joshi SR. Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of eastern himalaya. Mycobiology. 2012;40:27-34.
25. You C, Han C, Wang X, et al. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep. 2012;39:9193-9201.
26. Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules. 2011;16: 8894-8918.
27. Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM. A preliminary assessment of silver nanoparticles inhibition of Monkeypox virus plaque formation. Nanoscale Res Lett. 2008;3:129-133.
28. Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM. Interaction of silver nanoparticles with Tacaribe virus. J Nanobiotechnol. 2010;8:19.
29. Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnol. 2010;8:1.
30. Lu L, Sun RW, Chen R, et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008;13:253-262.
31. Sun L, Singh AK, Vig K, Pillai S, Shreekumar R, Singh SR. Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol. 2008;4:149-158.
32. Baram-Pinto D, Shukla S, Perkas N, Gedanken A, Sarid R. Inhibition of herpes simplex virus type 1infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem. 2009;20:1497-1502.
33. Mehrbod P, Motamed N, Tabatabaian M, et al. In vitro antiviral effect of "nanosilver" on influenza virus. DARU. 2009;17:88-93.
34. Galdiero S, Falanga A, Vitiello M, et al. Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1infectivity. Peptides. 2008;29:1461-1471.
35. Patil HB, Borse SV, Patil DR, Patil UK, Patil HM. Synthesis of silver nanoparticles by microbial method and their characterization. Arch Phys Res. 2011;2:155-158.
36. Moharrer S, Mohammadi B, Gharamohammadi RA, Yargoli M. Biological synthesis of silver nanoparticles by Aspergillus flavus, isolated from soil of Ahar copper mine. Indian J Sci Technol. 2012;5: 2443-2444.
37. Bawaskar M, Gaikwad S, Ingle A, et al. A new report on mycosynthesis of silver nanoparticles by Fusarium culmorum. Curr Nanosci. 2010;6: 376-380.
38. Chan YS, Mashitah MD. Instantaneous biosynthesis of silver nanoparticles by selected macro fungi. Aust J Basic Appl Sci. 2012;6: 222-226.
39. Vahabi K, Mansoori GA, Karimi S. Biosynthesis of silver nanoparticles by fungus Trichoderma reesei. Insciences J. 2011;1:65-79.
40. Sangappa M, Thiagarajan P. Mycobiosynthesis and characterization of silver nanoparticles from Aspergillus niger: a soil fungal isolate. International Journal of Life Sciences Biotechnology and Pharma Research. 2012;1:282.
41. Ahmad A, Mukherjee P, Senapati S, et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B. 2003;28:313-319.
42. Montes-Burgos I, Walczyk D, Hole P, Smith J, Lynch I, Dawson K. Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res. 2010;12:47-53.
43. Wright M. NanoParticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. In: Soloviev M, editor. Nanoparticles in Biology and Medicine. New York, NY: Humana Press; 2012.
44. Salem HF, Eid K, Sharaf MA. Formulation and evaluation of silver nanoparticles as antibacterial and antifungal agents with a minimal cytotoxic effect. Int J Drug Deliv. 2011;3:293-304.
45. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. Fusing structure and function: a structural view of the herpes virus entry machinery. Nat Rev Microbiol. 2011;9:369-381.
46. Chang A, Dutch RE. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses. 2012;4:613-636.
47. Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol. 2005;3:6.